Moreover, BRD2 inhibition has specific effects on invasiveness: as noted earlier, BRD2 via NF-κB signaling promotes mesenchymal transition and invasion in GBM (Marchant et al., 2023). The gene discussed is BRD2; the disease is glioblastoma.